LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 207 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $214,000 | -27.0% | 1,900 | 0.0% | 0.07% | -22.2% |
| Q4 2021 | $293,000 | +10.6% | 1,900 | 0.0% | 0.09% | +3.4% |
| Q3 2021 | $265,000 | +6.4% | 1,900 | 0.0% | 0.09% | +7.4% |
| Q2 2021 | $249,000 | -14.1% | 1,900 | 0.0% | 0.08% | -19.8% |
| Q1 2021 | $290,000 | +36.2% | 1,900 | 0.0% | 0.10% | +4.1% |
| Q2 2020 | $213,000 | -25.0% | 1,900 | -51.3% | 0.10% | -38.6% |
| Q1 2020 | $284,000 | -30.2% | 3,900 | 0.0% | 0.16% | -6.0% |
| Q4 2019 | $407,000 | +4.9% | 3,900 | 0.0% | 0.17% | -5.1% |
| Q3 2019 | $388,000 | -32.0% | 3,900 | -22.0% | 0.18% | -29.5% |
| Q2 2019 | $571,000 | -9.2% | 5,000 | 0.0% | 0.25% | -10.0% |
| Q1 2019 | $629,000 | – | 5,000 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
| Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
| Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
| WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
| Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
| FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
| Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
| Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |